Net income decreased 27.2%
Net income changed -27.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed -27.2% from the comparable as-filed period.
Cash & equivalents changed +62.9% from the comparable as-filed period.
SBC / revenue changed -348 basis points from the comparable as-filed period.
Gross margin changed -164 basis points from the comparable as-filed period.
Stock-based compensation changed -28.1% from the comparable as-filed period.
Operating income changed -13.6% from the comparable as-filed period.
Operating margin changed -20 basis points from the comparable as-filed period.
Revenue changed -1.5% from the comparable as-filed period.
Research & development changed -0.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed -3.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.